Asset Manager

Updated:

DexCare

DexCare was built from within Providence, the large health system based in the Pacific Northwest, after its team identified that health systems possess...

DexCare

DexCare was built from within Providence, the large health system based in the Pacific Northwest, after its team identified that health systems possess capacity but cannot surface it to patients due to disjointed scheduling and navigation tools. The platform launched in 2021 and acquired eCommerce technology firm Womp in 2022 to bring online shopping-style user experiences to healthcare appointment booking. DexCare's software integrates with electronic medical records (EMR) and access points to centralize patient routing across multiple care modalities — urgent care, primary care, and specialty visits. The company reports that its health system customers achieve a 40% increase in net-new patients and a five-day reduction in wait times. Named clients include Providence, Kaiser Permanente, Piedmont Healthcare, SSM Health, and Texas Health Resources. DexCare is headquartered in Renton, Washington, and as of mid-2026 has not disclosed its valuation, AUM, or funding history. The firm likely operates as an asset-light software company rather than a capital deployment vehicle, with its revenue derived from platform subscription or transaction fees paid by health systems. The company's structural differentiator is its origin: DexCare was incubated inside a health system, Providence, rather than built as a standalone startup or acquired by a private equity firm. This lineage gave it direct access to clinical and operational pain points, shaping a product that targets capacity loss rather than just appointment booking.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Renton

Corporate office

Renton, WA, United States

Sector focus

Digital HealthAI/MLHealthcare Services

Frequently asked questions

Who runs investment decisions at DexCare?

DexCare has not publicly disclosed its CEO, CIO, or investment committee as of mid-2026. The company was launched from within Providence and does not appear to operate as a traditional investment vehicle.

How does DexCare source proprietary deal flow?

As a patient navigation platform, DexCare does not source or execute investment deals. Its business involves selling software services to health systems, not deploying capital into portfolio companies.

Is DexCare structured as a single family office or does it operate more like a venture firm?

DexCare is neither a family office nor a venture firm. It is a healthcare technology company that provides a SaaS platform to hospitals and health systems to improve patient access and scheduling efficiency.

Does DexCare participate in fund commitments or only direct deals?

DexCare does not participate in fund commitments or direct investment deals. Its activities are limited to operating a software business, not investing or capital allocation.

What investment stages does DexCare typically target?

DexCare is not an investment firm and does not target any investment stages. It operates as a developer and seller of patient navigation technology.

Which sectors does DexCare explicitly avoid?

DexCare does not avoid any sectors as an investor, since it does not invest. As a software provider, its focus is exclusively on the healthcare sector, specifically health system patient access and scheduling.

How is DexCare related to Providence?

DexCare was launched from within Providence, the large health system based in the Pacific Northwest, in 2021. The company's product was built based on problems observed inside Providence's own operations. It is a separate entity from Providence but retains the same headquarters city of Renton, Washington.

Where does the underlying wealth come from?

DexCare is a technology company, not a family office, so there is no underlying family wealth. The platform generates revenue from subscription or transaction fees paid by client health systems.

Does DexCare maintain philanthropic structures, and how are they separated?

DexCare has not disclosed any philanthropic structures, foundations, or separate charitable entities. As an operating company, it does not manage any deployed capital for philanthropic purposes.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo